Jupiter Life Line Hospitals Gears Up for Q3 Reveal on 30th January; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Jupiter Life Line Hospitals’ Q3 results FY26 are scheduled to be announced on 30th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Jupiter Life Line Hospitals Q3 Results 2026 Preview

• Jupiter Life Line Hospitals’ revenue is expected to be in the range of ₹320.64 crore, a 4.20% YoY decrease. 
• Profit After Tax, or PAT, is projected to rise by 1.67% YoY. 
• Net profit is ₹252.51 crore, up 1.67% YoY 
• EBITDA to fall 4.33%

Jupiter Life Line Hospitals Share Performance 

• Over the past six months, Jupiter Life Line Hospitals’s share price has fallen by 8.95% to ₹28.00.
• Moreover, over the past year, the stock has increased by 12.87%.
• Despite this weak short-term performance, Jupiter Life Line Hospitals’ stock has delivered a financially sound 239.85% return over the past 5 years.
• As of 29th January 2026, the stock traded at ₹28.00 per share.

Key Factors to Watch for Jupiter Life Line Hospitals Q3 Results FY26 

• Revenue & Patient Volume Growth: Monitor topline growth driven by inpatient (IPD) and outpatient (OPD) demand across existing hospitals.
  
• Profitability & Margins: Watch EBITDA, PAT and margin trends amid rising costs and expansion‑related expenses.
  
• Occupancy & ARPOB Metrics: Check occupancy rates and Average Revenue Per Occupied Bed (ARPOB) as key operational indicators.
  
• Expansion & Capex Impact: Look for updates on new hospital projects (e.g., Dombivli, Pune/South Pune) and their near‑term earnings impact.
  
• Interest Costs & Balance Sheet: Track interest expenses, debt levels and working capital trends amid financing of growth initiatives.
  

Final Thoughts

Jupiter Life Line Hospitals will announce its Q3 FY26 results on 30th January 2026. Analysts expect 4.30% YoY revenue growth, a 1.67% rise in PAT, and a 4.33% fall in EBITDA. Jupiter Life Line Hospitals focuses on providing multi-speciality tertiary and quaternary healthcare services through advanced hospital facilities, delivering comprehensive patient‑centric care across a wide range of specialities with state‑of‑the‑art technology, and expanding its network to enhance accessibility in Western and other regions of India.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here